---
title: "Elevate pLVAD completes early feasibility study"
date: "2023-08-22T13:27:11.000Z"
publishedDate: "22 août 2023"
summary: "Enrolment has been completed in the US Food and Drug Administration (FDA)-approved early feasibility study (EFS) of the Elevate (Magenta Medical) percutaneous left ventricular assist device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication. All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital (New York, USA), St Francis Hospital and [&#8230;] The post Elevate pLVAD completes early feasibility study appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/elevate-pvlad-completes-efs/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-08-22-elevate-plvad-completes-early-feasibility-study"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/02/Generic-innovation.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/elevate-pvlad-completes-efs/"
---

![Elevate pLVAD completes early feasibility study](https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/02/Generic-innovation.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/elevate-pvlad-completes-efs/*

## L’essentiel

Enrolment has been completed in the US Food and Drug Administration (FDA)-approved early feasibility study (EFS) of the Elevate (Magenta Medical) percutaneous left ventricular assist device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication. All 15 study patients were enrolled and successfully treated at Mount Sinai Hospital (New York, USA), St Francis Hospital and [&#8230;] The post Elevate pLVAD completes early feasibility study appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/elevate-pvlad-completes-efs/
